NO982907D0 - Tyrosinderivater som <alfa>-v-integrininhibitorer - Google Patents
Tyrosinderivater som <alfa>-v-integrininhibitorerInfo
- Publication number
- NO982907D0 NO982907D0 NO982907A NO982907A NO982907D0 NO 982907 D0 NO982907 D0 NO 982907D0 NO 982907 A NO982907 A NO 982907A NO 982907 A NO982907 A NO 982907A NO 982907 D0 NO982907 D0 NO 982907D0
- Authority
- NO
- Norway
- Prior art keywords
- alfa
- integrin inhibitors
- tyrosine derivatives
- tyrosine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C247/00—Compounds containing azido groups
- C07C247/02—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton
- C07C247/04—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/08—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/06—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/14—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19548709A DE19548709A1 (de) | 1995-12-23 | 1995-12-23 | Tyrosinderivate |
| PCT/EP1996/005646 WO1997023451A1 (de) | 1995-12-23 | 1996-12-16 | Tyrosin-derivate als alpha-v-integrin-inhibitoren |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO982907L NO982907L (no) | 1998-06-22 |
| NO982907D0 true NO982907D0 (no) | 1998-06-22 |
Family
ID=7781401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO982907A NO982907D0 (no) | 1995-12-23 | 1998-06-22 | Tyrosinderivater som <alfa>-v-integrininhibitorer |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0879227A1 (no) |
| JP (1) | JP2000502664A (no) |
| KR (1) | KR19990076676A (no) |
| AU (1) | AU1301697A (no) |
| BR (1) | BR9612201A (no) |
| CA (1) | CA2241149A1 (no) |
| CZ (1) | CZ195198A3 (no) |
| DE (1) | DE19548709A1 (no) |
| HU (1) | HUP9903716A2 (no) |
| NO (1) | NO982907D0 (no) |
| PL (1) | PL327185A1 (no) |
| SK (1) | SK78398A3 (no) |
| WO (1) | WO1997023451A1 (no) |
| ZA (1) | ZA9610725B (no) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19629816A1 (de) | 1996-07-24 | 1998-01-29 | Hoechst Ag | Neue Cycloalkyl-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten |
| US5900414A (en) * | 1996-08-29 | 1999-05-04 | Merck & Co., Inc. | Methods for administering integrin receptor antagonists |
| DE69720062D1 (de) * | 1996-12-09 | 2003-04-24 | Lilly Co Eli | Integrin antagonisten |
| US6245809B1 (en) | 1996-12-09 | 2001-06-12 | Cor Therapeutics Inc. | Integrin antagonists |
| US6559144B2 (en) | 1997-02-13 | 2003-05-06 | Merck Patent Gesellschaft Mit | Bicyclic amino acids |
| DE19705450A1 (de) * | 1997-02-13 | 1998-08-20 | Merck Patent Gmbh | Bicyclische aromatische Aminosäuren |
| CA2300121A1 (en) * | 1997-08-22 | 1999-03-04 | F. Hoffmann-La Roche Ag | N-alkanoylphenylalanine derivatives |
| NZ502813A (en) * | 1997-08-22 | 2002-10-25 | F | N-aroylphenylalanine derivatives as inhibitors of the interaction between a4 containing integrins and VCAM-1 |
| US6455550B1 (en) | 1997-08-22 | 2002-09-24 | Hoffmann-La Roche Inc. | N-alkanoylphenylalanine derivatives |
| US6420558B1 (en) | 1998-04-09 | 2002-07-16 | Meiji Seika Kaisha, Ltd. | Aminopiperidine derivates as integrin αvβ3 antagonists |
| AU5239999A (en) * | 1998-07-31 | 2000-02-21 | Eli Lilly And Company | Heterocyclyl sulphonamide derivatives |
| DE19842415A1 (de) * | 1998-09-16 | 2000-03-23 | Merck Patent Gmbh | Pharmazeutische Zubereitung |
| US6677360B2 (en) | 1998-12-16 | 2004-01-13 | Bayer Aktiengesellschaft | Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| ES2249059T3 (es) * | 1998-12-16 | 2006-03-16 | Bayer Healthcare Ag | Nuevos compuestos de bifenilo y analogos de bifenilo como antagonista de integrina. |
| US6833373B1 (en) | 1998-12-23 | 2004-12-21 | G.D. Searle & Co. | Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| CA2359112A1 (en) | 1999-01-22 | 2000-07-27 | Elan Pharmaceuticals, Inc. | Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
| AU2623900A (en) * | 1999-01-22 | 2000-08-07 | American Home Products Corporation | Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| JP2002535314A (ja) * | 1999-01-22 | 2002-10-22 | エラン ファーマシューティカルズ，インコーポレイテッド | Ｖｌａ−４により媒介される白血球接着を阻害する化合物 |
| US6436904B1 (en) | 1999-01-25 | 2002-08-20 | Elan Pharmaceuticals, Inc. | Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| US6344484B1 (en) | 1999-02-12 | 2002-02-05 | 3-Dimensional Pharmaceuticals, Inc. | Tyrosine alkoxyguanidines as integrin inhibitors |
| EP1028114A1 (en) * | 1999-02-13 | 2000-08-16 | Aventis Pharma Deutschland GmbH | Novel guanidine derivatives as inhibitors of cell adhesion |
| HUP0200155A3 (en) | 1999-02-18 | 2005-04-28 | Hoffmann La Roche | Thioamide derivatives, pharmaceutical compositions containing them and their use |
| DE60009883T2 (de) | 1999-03-01 | 2005-04-07 | Elan Pharmaceuticals, Inc., San Francisco | Alpha-aminoessigsäure derivate als alpha 4 beta 7- rezeptor antagonisten |
| CA2368049A1 (en) | 1999-04-13 | 2000-10-19 | Basf Aktiengesellschaft | Integrin receptor ligands |
| WO2001010844A1 (en) | 1999-08-05 | 2001-02-15 | Meiji Seika Kaisha, Ltd. | φ-AMINO-α-HYDROXYCARBOXYLIC ACID DERIVATIVES HAVING INTEGRIN αvβ3 ANTAGONISM |
| DE60021521T4 (de) | 1999-09-29 | 2006-09-21 | Ortho-Mcneil Pharmaceutical, Inc. | Isonipecotamide zur behandlung von integrin vermittelten störungen |
| US6531495B1 (en) | 1999-10-02 | 2003-03-11 | Aventis Pharma Deutschland Gmbh | 2′-Substituted 1,1′-biphenyl-2-carboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them |
| AU781747B2 (en) * | 1999-10-08 | 2005-06-09 | Meiji Seika Kaisha Ltd. | 3-aminopiperidine derivatives as integrin alphavbeta3 antagonists |
| US6486174B2 (en) | 2000-08-07 | 2002-11-26 | 3-Dimensional Pharmaceuticals, Inc. | Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists |
| US20020037897A1 (en) * | 2000-08-07 | 2002-03-28 | 3-Dimensional Pharmaceuticals, Inc. | Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists |
| CA2436130A1 (en) | 2001-01-29 | 2002-08-08 | 3-Dimensional Pharmaceuticals, Inc. | Substituted indoles and their use as integrin antagonists |
| FR2822827B1 (fr) * | 2001-03-28 | 2003-05-16 | Sanofi Synthelabo | Nouveaux derives de n-(arylsulfonyl) beta-aminoacides comportant un groupe aminomethyle substitue, leur procede de preparation et les compositions pharmaceutiques en contenant |
| JP2004529918A (ja) | 2001-04-09 | 2004-09-30 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | インテグリンに由来する疾患の治療のためのキナゾリンおよびキナゾリン類似化合物 |
| US6872730B2 (en) | 2001-04-27 | 2005-03-29 | 3-Dimensional Pharmaceuticals, Inc. | Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists |
| WO2003008373A1 (de) * | 2001-07-19 | 2003-01-30 | Merck Patent Gmbh | Tyrosinhydrazide |
| TW200307671A (en) | 2002-05-24 | 2003-12-16 | Elan Pharm Inc | Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins |
| TWI281470B (en) | 2002-05-24 | 2007-05-21 | Elan Pharm Inc | Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
| CN101273035A (zh) | 2005-09-29 | 2008-09-24 | 伊兰制药公司 | 抑制由vla-4介导的白细胞粘附的氨基甲酸酯化合物 |
| NZ567270A (en) | 2005-09-29 | 2011-06-30 | Elan Pharm Inc | Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| EA017110B1 (ru) | 2006-02-27 | 2012-09-28 | Элан Фамэсьютикэлс, Инк. | ПИРИМИДИНИЛСУЛЬФОНАМИДНЫЕ СОЕДИНЕНИЯ (ВАРИАНТЫ), СПОСОБ ПОЛУЧЕНИЯ ПИРИМИДИНИЛСУЛЬФОНАМИДНЫХ СОЕДИНЕНИЙ (ВАРИАНТЫ), ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЯ, ОПОСРЕДОВАННОГО ИНТЕГРИНОМ α4, СПОСОБ СНИЖЕНИЯ И/ИЛИ ПРЕДУПРЕЖДЕНИЯ ВОСПАЛИТЕЛЬНОГО КОМПОНЕНТА ЗАБОЛЕВАНИЯ ИЛИ АУТОИММУННОГО ОТВЕТА |
| MX2011011326A (es) | 2009-04-27 | 2012-02-13 | Elan Pharm Inc | Antagonistas de piridinona de las integrinas alfa-4. |
| WO2012103328A1 (en) * | 2011-01-26 | 2012-08-02 | The Methodist Hospital Research Institute | Labeled, non- peptidic multivalent integrin alpha -v - beta - 3 antagonists, compositions containing them and their use |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL99537A (en) * | 1990-09-27 | 1995-11-27 | Merck & Co Inc | Fibrinogen receptor antagonists and pharmaceutical preparations containing them |
| NZ239846A (en) * | 1990-09-27 | 1994-11-25 | Merck & Co Inc | Sulphonamide derivatives and pharmaceutical compositions thereof |
-
1995
- 1995-12-23 DE DE19548709A patent/DE19548709A1/de not_active Withdrawn
-
1996
- 1996-12-16 PL PL96327185A patent/PL327185A1/xx unknown
- 1996-12-16 HU HU9903716A patent/HUP9903716A2/hu unknown
- 1996-12-16 WO PCT/EP1996/005646 patent/WO1997023451A1/de not_active Application Discontinuation
- 1996-12-16 KR KR1019980704788A patent/KR19990076676A/ko not_active Application Discontinuation
- 1996-12-16 EP EP96944578A patent/EP0879227A1/de not_active Withdrawn
- 1996-12-16 AU AU13016/97A patent/AU1301697A/en not_active Abandoned
- 1996-12-16 BR BR9612201A patent/BR9612201A/pt not_active Application Discontinuation
- 1996-12-16 CA CA002241149A patent/CA2241149A1/en not_active Abandoned
- 1996-12-16 SK SK783-98A patent/SK78398A3/sk unknown
- 1996-12-16 CZ CZ981951A patent/CZ195198A3/cs unknown
- 1996-12-16 JP JP9523282A patent/JP2000502664A/ja active Pending
- 1996-12-19 ZA ZA9610725A patent/ZA9610725B/xx unknown
-
1998
- 1998-06-22 NO NO982907A patent/NO982907D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2241149A1 (en) | 1997-07-03 |
| BR9612201A (pt) | 1999-07-13 |
| ZA9610725B (en) | 1997-06-26 |
| DE19548709A1 (de) | 1997-07-03 |
| HUP9903716A2 (hu) | 2000-03-28 |
| SK78398A3 (en) | 1998-11-04 |
| MX9804971A (es) | 1998-09-30 |
| EP0879227A1 (de) | 1998-11-25 |
| JP2000502664A (ja) | 2000-03-07 |
| NO982907L (no) | 1998-06-22 |
| PL327185A1 (en) | 1998-11-23 |
| KR19990076676A (ko) | 1999-10-15 |
| AU1301697A (en) | 1997-07-17 |
| CZ195198A3 (cs) | 1998-11-11 |
| WO1997023451A1 (de) | 1997-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO982907D0 (no) | Tyrosinderivater som <alfa>-v-integrininhibitorer | |
| NO986090D0 (no) | Fenylalaninderivater som integrininhibitorer | |
| NO992725D0 (no) | 6-Fenylpyridyl-2-amin-derivater anvendelige som NOS-inhibitorer | |
| ATE198329T1 (de) | Chinazolin-derivate | |
| ATE205483T1 (de) | Chinazolinderivate | |
| NL350032I2 (nl) | Pyrazool-4-yl-benzoylderivaten de toepassing ervanals herbiciden | |
| DK0818448T3 (da) | Cycloalkanopyridiner som CETP-inhibitorer | |
| DK1244647T3 (da) | Quinzolinderivater som VIGF-inhibitorer | |
| ATE248812T1 (de) | Arylsulfonylhydroxamsäurederivate | |
| DK1003720T3 (da) | Aryloxyarylsulfonylaminohydroxamsyrederivater | |
| DK1049695T3 (da) | 2-Phenyl-substituerede imidazotriazinoner som phosphodiesterase-inhibitorer | |
| DK1027332T3 (da) | Hidtil ukendte lactametalloproteaseinhibitorer | |
| ATE234276T1 (de) | Diacylhydrazinderivate als integrin-inhibitoren | |
| DE69910714D1 (de) | Pflanzenaktivierungsmittel | |
| DE69817671D1 (de) | Antragsrolle | |
| NO20010331D0 (no) | Ftalazinderivater som fosfodiesterase 4-inhibitorer | |
| IS5562A (is) | Nýjar díhýdroxýhexanósýru afleiður | |
| FI950512A0 (fi) | Ny konserveringssammansaettning | |
| MA26543A1 (fr) | Derives de pyrrolopyrrolone comme inhibiteurs d'elastase de neutrophiles. | |
| NO963340L (no) | Sulfonyl- eller sulfinylbenzoylguanidinderivater | |
| BR9708595A (pt) | Utilização de derivados de 2,5- di-hidroxibenzenossulfonicos | |
| ATE221065T1 (de) | Amidinderivate als inhibitoren von no-synthase | |
| MA26544A1 (fr) | Derives de pyrrolopyrrolone comme inhibiteurs d'elastase de neutrophiles | |
| NO996244D0 (no) | Pyrrolidinkarboksylsyrederivater som endotelinantagonister | |
| NO20000094D0 (no) | 6-Azaurcilderivater som IL-5 inhibitorer |